Ads
related to: opdivo yervoy combination lung cancer
Search results
BMS Opdivo and Yervoy combo misses primary endpoint in Phase III NSCLC trial
Clinical Trials Arena via Yahoo Finance· 2 weeks agoBristol Myers Squibb’s (BMS) blockbuster cancer therapies Opdivo (nivolumab) and Yervoy (ipilimumab)...
Bristol Myers' Opdivo-Yervoy combo meets main goal in liver cancer trial
Reuters via Yahoo News· 2 months agoThe treatment, tested in patients with advanced hepatocellular carcinoma (HCC), met the main goal of...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 8 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
Bristol Myers (BMY) Updates Action Date for Subcutaneous Opdivo
Zacks via Yahoo Finance· 2 days agoBristol Myers Squibb BMY announced that the FDA will now decide on the biologics license application...
Bristol Myers' (BMY) Opdivo Label Expansion Filings Get Accepted
Zacks via Yahoo Finance· 3 months agoBristol Myers (BMY) announces the acceptance of its regulatory filings for the perioperative Opdivo...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 2 weeks agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
The Wall Street Journal· 2 weeks agoHEALTH NEWS Bristol Myers Squibb said on Friday that its trial evaluating a combination of cancer...
Bristol Myers (BMY) Announces Upbeat Data From NSCLC Study
Zacks via Yahoo Finance· 12 months agoBristol Myers (BMY) reports encouraging four-year clinical efficacy results from its lung cancer...
Bristol Myers' (BMY) Opdivo Meets Main Goal in Melanoma Study
Zacks via Yahoo Finance· 2 years agoBristol Myers' (BMY) immuno-oncology drug Opdivo demonstrates a statistically significant and...
Bristol Myers' (BMY) Opdivo Combos Get FDA Nod for ESCC
Zacks via Yahoo Finance· 2 years agoBristol Myers (BMY) secures an FDA approval for two Opdivo-based regimens as the first-line...
Ads
related to: opdivo yervoy combination lung cancer